1Banks AD. Women and heart disease: Missed opportunities[J]. Mid-wifery Womens Health,2008,53(5) :430-439.
2Rosano GM,Vitale C,Fini M. Hormone replacement therapy and car dioprotection:What is good and what is bad for the cardiovascular system[J]. Ann NY Acad Sci,2006,1 092:341-348.
3Stevenson JC. HRT and the primary prevention of cardiovascular dis ease[J]. Maturitas, 2007,20,57 (1): 31-34.
6Rossouw JE, Auderson GL, Prentice RL, et al. Writing group for the womens health initiative investigations risks and benefits of estrogen plus progestin in healthy postmenopausal women principal result from the womens health initiative randomized and controlled trial [J]. JAMA,2002,288(3) :321-333.
7Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postm enopausal women[J]. JAMA, 2002,288(7):605-613.
8Rossouw J, Prentice R , Manson J MD, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause[J]. JAMA,2007,297(13):1 465-1 477.
2Wagner JD,Anthony MS,Cline JM.Soy phytoestrogens:research on benefits and risks.Clin Obstet Gynecol,2001,44(4):843
3Geller SE,Studee L.Botanical and dietary supplements for menopausal symptoms:what works,what does not.J Womens Health(Larchmt),2005,14(7):634
4Hyder SM,Huang JC,Nawaz Z,et al.Regulation of vascular endothelial growth factor expression by estrogens and progestins.Environ Health Perspect,2000,108(Suppl 5):785
6Celik-Ozenci C,Akkoyunlu G,Kayisli UA,et al.Localization of vascular endothelial growth factor in the zona pellucida of developing ovarian follicles in the rat:a possible role in destiny of follicles.Histochem Cell Biol,2003,120(5):383
7Faraci FM,BrianJE Jr.Nitric oxide and the cerebral circulation.Stroke,1994,25(3):692
8Hishikawa K,Nakaki T,Marumo T,et al.Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells.FEBS Lett,1995,360(3):291
9Schmidt PJ,Niernan L,Danaceau MA,et al. Estrogen replacement in perimenopause related depression: a preliminary report[J]. Am Journal Obstetical Gynecology, 2000,183: 414-420.
10Mriam B. Rosenthal, psychiatric disorders end menopause: evaluation end treatment[J]. Menopause Management, 1993,1: 35.
3Bath PM,Gray LJ.Association between hormone replacement therapy and subsequent stroke:A meta-analysis.J Neurol Neurosurg Psychiatry,2005,76:838.
4Manson JE,Allison MA,Rossouw JE,et al.Estrogen therapy and coronary-artery calcification.NEJM,2007,356:2591-2602.
5Grodstein F,Manson JE,Colditz GA,et al.A prospective,observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.Ann Intern Med,2000,133:933-941.
6Brownley KA,Hinderliter AL,West SG,et al.Cardiovascular effects of 6 months of hormone replacement therapy versus placebo:Differences associated with years since menopause.Am J Obstet Gynecol,2004,190:1052-1058.
7Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal womenprincipal results from the women's health initiative randomized controlled trial.JAMA,2002,288:321-333.
8Anderson GL,Limacher M,Assaf AR,et al.Effects of conjugated equine estrogen in postmenopausal women with hysterectomy.The Women's Health Initiative Randomized Controlled Trial.JAMA,2004,291:1701-1712.
9Wierzbicki AS.Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention? Curr Med Res Opin,2005,21:299-305.
10Madsen JS,Kristensen SR,Gram J,et al.Positive impact of hormone replacement therapy on the fibrinolytic system:A longterm randomized controlled study in healthy postmenopausal women.J Thromb Haemost,2003,1:1984-1991.
